Disopyramide phosphate and Dyspnea - a phase IV clinical study of FDA data

Summary:

Dyspnea is reported as a side effect among people who take Disopyramide phosphate (disopyramide phosphate), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Proair Hfa, and have Cardiac disorder.

The phase IV clinical study analyzes which people have Dyspnea when taking Disopyramide phosphate. It is created by eHealthMe based on reports of 470 people who have side effects when taking Disopyramide phosphate from the FDA, and is updated regularly.

What is Disopyramide phosphate?

Disopyramide phosphate has active ingredients of disopyramide phosphate. It is often used in heart palpitations. eHealthMe is studying from 485 Disopyramide phosphate users. Check the latest studies of Disopyramide phosphate.

What is Dyspnea?

Dyspnea (difficult or laboured breathing) is found to be associated with 3,720 drugs and 6,067 conditions by eHealthMe. Check the latest studies of Dyspnea.

On Jul, 06, 2026

470 people reported to have side effects when taking Disopyramide phosphate.
Among them, 14 people (2.98%) have Dyspnea.

Could Disopyramide phosphate cause Dyspnea?

Among these 14 people:

How long have people been on Disopyramide phosphate when they have Dyspnea? *

What is the gender of people who have Dyspnea when taking Disopyramide phosphate? *

female: 76.92 %
male: 23.08 %

What is the age of people who have Dyspnea when taking Disopyramide phosphate? *

What are other drugs people take besides Disopyramide phosphate? *

What are other side effects people have besides Dyspnea? *

Weakness: 5 people, 35.71%
Fatigue (feeling of tiredness): 5 people, 35.71%
Drug Ineffective: 5 people, 35.71%
Chest Pain: 4 people, 28.57%
Stress And Anxiety: 3 people, 21.43%
Feeling Abnormal: 3 people, 21.43%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 21.43%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 14.29%
Calcinosis (calcium deposits in any soft tissue): 2 people, 14.29%
Cardiac Disorder: 2 people, 14.29%

What are the existing conditions these people have? *

Cardiac Disorder: 7 people, 50.00%
Hypertrophic Cardiomyopathy (a condition in which the heart muscle becomes abnormally thick): 4 people, 28.57%
Neuropathy Peripheral (surface nerve damage): 3 people, 21.43%
Laxative Supportive Care: 3 people, 21.43%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 14.29%
Sleep Disorder: 2 people, 14.29%
Primary Immunodeficiency Syndrome: 2 people, 14.29%
Pain: 2 people, 14.29%
Immunodeficiency: 2 people, 14.29%
Heart Attack: 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Disopyramide phosphate and have Dyspnea?

- Check whether Dyspnea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Disopyramide phosphate:

Disopyramide phosphate (485 reports)

Dyspnea treatments and more:

Dyspnea (661,578 reports)

Browse all side effects of Disopyramide phosphate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea:

Dyspnea (3,720 drugs)

Browse all the conditions that are associated with Dyspnea:

Dyspnea (6,067 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on disopyramide phosphate (the active ingredients of Disopyramide phosphate) and Disopyramide phosphate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.